Latest Regulatory Approval News

Page 17 of 346
Memphasys has reported record September-quarter invoiced revenue of A$211,000 as its Felix fertility device moves into more international markets. The commercial progress comes alongside A$3.5 million in funding, but the loan still requires shareholder approval for conversion into notes.
Ada Torres
Ada Torres
13 Oct 2026
Orthocell says Remplir was placed successfully in five complex robotic prostatectomy cases, with no device-related complications reported over approximately 12 months. The preliminary results will guide a larger prospective trial ahead of a planned US expansion for the nerve repair product.
Ada Torres
Ada Torres
13 Oct 2026
Arena REIT says Edge Early Learning has agreed or signed term sheets to sell a further 22 centre businesses, including all seven remaining Edge-operated centres at Arena properties. Rent continues to flow across the 27 affected properties, but operator changes still require due diligence, approvals and lease assignments.
Eva Park
Eva Park
13 Oct 2026
Echo IQ has secured an FDA supervisory review of the regulator’s Not Substantially Equivalent decision for EchoSolv HF. The review creates a formal route for reconsideration, but does not change the current regulatory determination or guarantee clearance.
Victor Sage
Victor Sage
12 Oct 2026
EBR Systems reported 40 WiSE commercial implants in Q3, down from 46 in Q2 and below its prior forecast, as leadership changes and a sales strategy reset disrupted activity. Higher Medicare reimbursement and progress at its new manufacturing facility offer potential offsets, but both remain dependent on execution and regulatory approval.
Victor Sage
Victor Sage
12 Oct 2026
New Zealand Rural Land Company’s 75%-owned partnership has conditionally agreed to sell five Hawke’s Bay orchards for $18.84 million, as uncertainty from the Kiwi Crunch administration continues to cloud FY26 earnings. Completion depends on Overseas Investment Office consent.
Ada Torres
Ada Torres
9 Oct 2026
High-Tech Metals will ask shareholders to approve a new identity, Beyond Discovery Limited, alongside a proposed ASX code change from HTM to BYD. The move signals a shift toward developing its Mt Fisher and Mt Eureka gold projects, but changes no assets, operations or capital structure.
Maxwell Dee
Maxwell Dee
8 Oct 2026
Pioneer Minerals has entered a voluntary suspension while it prepares an announcement covering a capital raise and material acquisition. Trading is expected to resume on 9 October 2026 or once the announcement is released, whichever comes first.
Maxwell Dee
Maxwell Dee
8 Oct 2026
Gold Fields’ proposed acquisition of BHP’s Kambalda Nickel Concentrator could give Lunnon Metals a new processing angle for its nearby Foster-Baker nickel assets. The opportunity remains exploratory, with completion not expected until 2027 and no commercial arrangement disclosed.
Maxwell Dee
Maxwell Dee
7 Oct 2026
Kalamazoo Resources has secured A$10 million from a Saudi-led strategic investor and existing shareholder YT International at a 29% premium to its last close. The funding gives the Ashburton Gold Project more room to advance drilling, feasibility work and the Xanadu prospect evaluation.
Maxwell Dee
Maxwell Dee
7 Oct 2026
Ovanti has reported a A$23.61 million FY2026 loss, A$21.27 million in operating cash outflows and only A$291,867 in cash at year end. The ASX-listed fintech has abandoned BNPL globally, but says its continuing operations and proposed funding initiatives provide a basis to keep trading despite a material going-concern uncertainty.
Victor Sage
Victor Sage
6 Oct 2026
Yugo Metals has secured six-year access to the private land covering its planned Petrovo drill sites in Bosnia and Herzegovina, paying EUR300,000 and issuing 18 million escrowed shares. An IP survey is due to begin next week, with drilling planned for the fourth quarter subject to approvals.
Maxwell Dee
Maxwell Dee
6 Oct 2026

Browse the archive

Full archive